Atlas Trials

Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study)

Clinical trial NCT04139798 · COMPLETED

Trial details

NCT number
NCT04139798
Sponsor
Bausch & Lomb Incorporated
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dry Eye Disease (DED)
Start date
2020-07-20
Primary completion
2021-03-12
Enrollment
599

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.